Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Longer Term Efficacy of Lanreotide Autogel/Depot (LAN) for Symptomatic Treatment of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Open Label Study Fisher, G. A., Wolin, E. M., Kunz, P. L., Liyanage, N., Mirakhur, B., Lowenthal, S., Pommier, R. F., Shaheen, M., Vinik, A. NATURE PUBLISHING GROUP. 2016: S457–S458
View details for Web of Science ID 000395764601483